Tau Therapeutics tautherapeutics.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, called Interlaced Therapy, capitalizes on the central role of calcium influx through T-type calcium channels during cancer cell growth. T-type calcium channel blockade with Tau's drugs is intended to arrest tumor cells at the most vulnerable metabolic point, amplifying the effects of conventional th...Show all

Tau Therapeutics is a clinical stage company developing oncology drugs for solid tumors that selectively inhibit the T-type calcium channel - a mechanism of action for cancer. The company's approach, called Interlaced Therapy, capitalizes on the cent...Show all

Company (Merged)

Phone: 434-974-6969

Fax:

600 East Water Street
Suite E
Charlottesville, 22902
Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tau Therapeutics $13.7M Aug 28, 2014
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tau Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Threshold Pharmaceuticals

Redwood City, California, United States
MergedThreshold Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of small molecule therapeutics based on Metabolic Targeting, an approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor and certain other diseased cells, Threshold's pipeline of drug candidates holds promise to be more effective and less toxic to healthy tissues than conventional drugs. Threshold's initial clinical foc...Show allLogin to see details

Trellis Bioscience

South San Francisco, California, United States
Alive / ActiveTrellis Bioscience, Inc. is a private, venture-funded, antibody company focused on the discovery and development of unique therapeutic antibodies from human B cells. Trellis developed its patented CellSpot antibody discovery platform, which enables the rapid identification of rare, superior antibodies directly from human blood. The Company is initially focused on infectious disease targets, with the lead program providing therapeutic antibodies directed against Respiratory Syncytial Virus.Login to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cancer diagnosis and imaging Feb 28, 2011 Aug 30, 2016 Patent
T-type calcium channel inhibitors for treatment of cancer Jan 10, 2014 Application